Grifols Profit Margin 2012-2019 | GRFS

Current and historical gross margin, operating margin and net profit margin for Grifols (GRFS) over the last 10 years. Profit margin can be defined as the percentage of revenue that a company retains as income after the deduction of expenses. Grifols net profit margin as of March 31, 2019 is 12.35%.
Grifols Annual Profit Margins
Grifols Quarterly Profit Margins
Sector Industry Market Cap Revenue
Medical Medical - Drug Manufacturing $13.758B $5.299B
Grifols, S.A., operates in the pharmaceutical-hospital sector engaged in the research, development and retailing of plasma derivates, products for intravenous therapy, clinical nutrition, diagnostic and hospital logistics systems. The Company operates its business through three divisions: Bioscience Division, Diagnostic Division and Hospital Division. The Bioscience division is engaged in the research, development, production and commercialization of plasma derivates. Diagnostic Division focuses on researching, developing, manufacturing and marketing diagnostics products for laboratory analysis, including products for Hospital Blood Banks and Transfusion Centers. Hospital Division provides non-biological products used in hospital pharmacies, surgery, nutritional support, fluid therapy and for other therapeutic uses. Grifols, S.A. is based in Barcelona, Spain.
Stock Name Country Market Cap PE Ratio
Zoetis (ZTS) United States $54.031B 34.52
Takeda Pharmaceutical (TAK) Japan $27.263B 8.00
Sage Therapeutics (SAGE) United States $9.342B 0.00
Ionis Pharmaceuticals (IONS) United States $9.027B 19.73
Neurocrine Biosciences (NBIX) United States $7.759B 0.00
Catalent (CTLT) United States $7.758B 31.14
Jazz Pharmaceuticals (JAZZ) Ireland $7.610B 10.43
Nektar Therapeutics (NKTR) United States $6.076B 9.90
Tilray (TLRY) Canada $4.905B 0.00
FibroGen (FGEN) United States $3.817B 0.00
United Therapeutics (UTHR) United States $3.396B 0.00
Taro Pharmaceutical Industries (TARO) Israel $3.362B 11.80
Arrowhead Pharmaceuticals (ARWR) United States $2.666B 401.71
PTC Therapeutics (PTCT) United States $2.551B 0.00
AMNEAL PHARMACEUTICALS, INC (AMRX) United States $2.061B 7.42
Xencor (XNCR) United States $1.981B 54.09
Portola Pharmaceuticals (PTLA) United States $1.867B 0.00
Pacira Pharmaceuticals (PCRX) United States $1.816B 87.96
Zogenix (ZGNX) United States $1.724B 0.00
USANA Health Sciences (USNA) United States $1.703B 14.80
Enanta Pharmaceuticals (ENTA) United States $1.702B 23.26
Ironwood Pharmaceuticals (IRWD) United States $1.693B 0.00
Tricida (TCDA) United States $1.689B 0.00
Madrigal Pharmaceuticals (MDGL) United States $1.617B 0.00
Heron Therapeutics (HRTX) United States $1.464B 0.00
Aerie Pharmaceuticals (AERI) United States $1.419B 0.00
Esperion Therapeutics (ESPR) United States $1.360B 0.00
Turning Point Therapeutics (TPTX) United States $1.326B 0.00
Corcept Therapeutics (CORT) United States $1.203B 17.16
ArQule (ARQL) United States $1.147B 0.00
Radius Health (RDUS) United States $1.102B 0.00
Theravance Biopharma (TBPH) Cayman Islands $0.930B 0.00
Spectrum Pharmaceuticals (SPPI) United States $0.921B 0.00
Endo (ENDP) Ireland $0.869B 1.40
Odonate Therapeutics (ODT) United States $0.756B 0.00
Aptorum Group (APM) China $0.743B 0.00
CannTrust Holdings (CTST) Canada $0.695B 0.00
Organogenesis Holdings (ORGO) United States $0.652B 0.00
Translate Bio (TBIO) United States $0.639B 0.00
TherapeuticsMD (TXMD) United States $0.639B 0.00
Aurinia Pharmaceuticals Inc (AUPH) Canada $0.566B 0.00
Crinetics Pharmaceuticals (CRNX) United States $0.561B 0.00
Dermira (DERM) United States $0.531B 0.00
Akebia Therapeutics (AKBA) United States $0.521B 0.00
ChemoCentryx (CCXI) United States $0.505B 0.00
GlycoMimetics (GLYC) United States $0.480B 0.00
Corbus Pharmaceuticals Holdings (CRBP) United States $0.474B 0.00
Siga Technologies (SIGA) United States $0.448B 1.06
Flexion Therapeutics (FLXN) United States $0.442B 0.00
BioSpecifics Technologies Corp (BSTC) United States $0.426B 21.48
Collegium Pharmaceutical (COLL) United States $0.416B 0.00
BioCryst Pharmaceuticals (BCRX) United States $0.407B 0.00
Karyopharm Therapeutics (KPTI) United States $0.391B 0.00
Rigel Pharmaceuticals (RIGL) United States $0.385B 0.00
KalVista Pharmaceuticals (KALV) United States $0.371B 0.00
Catalyst Pharmaceuticals (CPRX) United States $0.368B 0.00
TCR2 Therapeutics (TCRR) United States $0.368B 0.00
MARKER THERAPEUTICS, INC (MRKR) United States $0.358B 0.00
Forty Seven (FTSV) United States $0.332B 0.00
OptiNose (OPTN) United States $0.324B 0.00
Harpoon Therapeutics (HARP) United States $0.314B 0.00
Molecular Templates (MTEM) United States $0.304B 0.00
CASI Pharmaceuticals (CASI) United States $0.300B 0.00
Xeris Pharmaceuticals (XERS) United States $0.299B 0.00
ImmunoGen (IMGN) United States $0.293B 0.00
Concert Pharmaceuticals (CNCE) United States $0.260B 0.00
Dova Pharmaceuticals (DOVA) United States $0.252B 0.00
Aratana Therapeutics (PETX) United States $0.247B 0.00
Verrica Pharmaceuticals (VRCA) United States $0.244B 0.00
La Jolla Pharmaceutical (LJPC) United States $0.237B 0.00
Lannett Co Inc (LCI) United States $0.228B 2.21
Recro Pharma (REPH) United States $0.224B 0.00
Marinus Pharmaceuticals (MRNS) United States $0.210B 0.00
Aldeyra Therapeutics (ALDX) United States $0.204B 0.00
ASSERTIO THERAPEUTICS, INC (ASRT) United States $0.204B 0.00
Ocular Therapeutix (OCUL) United States $0.189B 0.00
Aclaris Therapeutics (ACRS) United States $0.187B 0.00
Galectin Therapeutics (GALT) United States $0.186B 0.00
AcelRx Pharmaceuticals (ACRX) United States $0.185B 0.00
Opexa Therapeutics (ACER) United States $0.185B 0.00
MEI Pharma (MEIP) United States $0.176B 0.00
Bio Blast Pharma (ENLV) Israel $0.172B 0.00
Nature's Sunshine Products (NATR) United States $0.171B 55.31
Taiwan Liposome, Unsponsored ADR (TLC) Taiwan $0.167B 0.00
Minerva Neurosciences (NERV) United States $0.165B 0.00
Ardelyx (ARDX) United States $0.162B 0.00
IMV INC (IMV) Canada $0.158B 0.00
Jounce Therapeutics (JNCE) United States $0.158B 0.00
Redhill Biopharma (RDHL) Israel $0.149B 0.00
Calithera Biosciences (CALA) United States $0.147B 0.00
Majesco Entertainment (PTE) United States $0.146B 0.00
Foamix Pharmaceuticals (FOMX) Israel $0.145B 0.00
Galmed Pharmaceuticals (GLMD) Israel $0.144B 0.00
Neon Therapeutics (NTGN) United States $0.128B 0.00
Tyme Technologies (TYME) United States $0.114B 0.00
Avenue Therapeutics (ATXI) United States $0.108B 0.00
Aquestive Therapeutics (AQST) United States $0.105B 0.00
Avadel Pharmaceuticals (AVDL) Ireland $0.103B 0.00
Bellicum Pharmaceuticals (BLCM) United States $0.102B 0.00
DURECT (DRRX) United States $0.099B 0.00
Champions Oncology (CSBR) United States $0.099B 0.00
Cumberland Pharmaceuticals (CPIX) United States $0.098B 70.00
China SXT Pharmaceuticals (SXTC) China $0.098B 0.00
Iterum Therapeutics (ITRM) Ireland $0.094B 0.00
Mast Therapeutics (SVRA) United States $0.094B 0.00
Cardiome Pharma (CORV) Canada $0.091B 0.00
Infinity Pharmaceuticals (INFI) United States $0.091B 0.00
Natural Alternatives (NAII) United States $0.089B 8.86
Capnia (SLNO) United States $0.088B 0.00
Nivalis Therapeutics (ALPN) United States $0.082B 0.00
MediWound (MDWD) Israel $0.082B 0.00
Entasis Therapeutics Holdings (ETTX) United States $0.080B 0.00
Adherex Technologies (FENC) United States $0.080B 0.00
Otonomy (OTIC) United States $0.079B 0.00
SCYNEXIS (SCYX) United States $0.071B 0.00
Novan (NOVN) United States $0.067B 0.00
ElectroCore (ECOR) United States $0.063B 0.00
Adamis Pharmaceuticals (ADMP) United States $0.061B 0.00
Melinta Therapeutics (MLNT) United States $0.059B 0.00
Neos Therapeutics (NEOS) United States $0.058B 0.00
CTI BioPharma (CTIC) United States $0.057B 0.00
Opiant Pharmaceuticals (OPNT) United States $0.055B 0.00
Dipexium Pharmaceuticals (PLXP) United States $0.050B 0.00
Zafgen (ZFGN) United States $0.050B 0.00
KemPharm (KMPH) United States $0.050B 0.00
Genocea Biosciences (GNCA) United States $0.049B 0.00
ProNAi Therapeutics (SRRA) Canada $0.048B 0.00
BioLineRx (BLRX) Israel $0.047B 0.00
AIT Therapeutics (AITB) Israel $0.046B 0.00
Lipocine (LPCN) United States $0.045B 0.00
Forward Pharma (FWP) Denmark $0.044B 0.00
Mannatechorporated (MTEX) United States $0.040B 0.00
ContraFect (CFRX) United States $0.039B 0.00
Bio-Path Holdings (BPTH) United States $0.038B 0.00
Tetraphase Pharmaceuticals (TTPH) United States $0.034B 0.00
ProPhase Labs (PRPH) United States $0.033B 0.00
PharmAthene (ALT) United States $0.031B 0.00
Heat Biologics (HTBX) United States $0.026B 0.00
Regulus Therapeutics (RGLS) United States $0.025B 0.00
Citius Pharmaceuticals (CTXR) United States $0.024B 0.00
GTx (ONCT) United States $0.023B 0.00
Biomerica (BMRA) United States $0.023B 0.00
Onconova Therapeutics (ONTX) United States $0.022B 0.00
Pain Therapeutics (SAVA) United States $0.021B 0.00
Summit Therapeutics (SMMT) United Kingdom $0.020B 1.64
CollPlant Holdings Sponsored ADR (CLGN) Israel $0.019B 0.00
Cyanotech (CYAN) United States $0.018B 0.00
Achieve Life Sciences (ACHV) United States $0.016B 0.00
HANCOCK JAFFE (HJLI) United States $0.016B 0.00
Shineco (TYHT) China $0.015B 0.00
ESSA Pharma (EPIX) Canada $0.015B 0.00
Tokai Pharmaceuticals (NVUS) United States $0.014B 0.00
Kitov Pharmaceuticals Holdings (KTOV) Israel $0.013B 0.00
VAXART, INC (VXRT) United States $0.012B 0.00
Eyegate Pharmaceuticals (EYEG) United States $0.011B 0.00
Ohr Pharmaceuticals (OHRP) United States $0.011B 0.00
Trillium Therapeutics (TRIL) Canada $0.010B 0.00
XTL Biopharmaceuticals (XTLB) Israel $0.010B 1.74
Sonoma Pharmaceuticals (SNOA) United States $0.010B 0.00
RXi Pharmaceuticals (PHIO) United States $0.009B 0.00
Tonix Pharmaceuticals Holding (TNXP) United States $0.009B 0.00
Ritter Pharmaceuticals (RTTR) United States $0.008B 0.00
Jaguar Animal Health (JAGX) United States $0.007B 0.00
Xenetic Biosciences (XBIO) United States $0.006B 0.00
Auris Medical Holding AG (EARS) Switzerland $0.005B 0.00
Midatech Pharma (MTP) United Kingdom $0.004B 0.00
DelMar Pharmaceuticals (DMPI) Canada $0.004B 0.00
Advanced Accelerator Applications (AAAP) France $0.000B 0.00
Oasmia Pharmaceutical AB (OASM) Sweden $0.000B 0.00
Patheon (PTHN) Netherlands $0.000B 0.00